Y.D. More Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$110K Buy
1,914
+68
+4% +$3.9K ﹤0.01% 271
2026
Q1
$112K Sell
1,846
-617
-25% -$36K ﹤0.01% 244
2025
Q4
$133K Sell
2,463
-771
-24% -$37.1K 0.01% 218
2025
Q3
$146K Buy
+3,234
New +$151K 0.01% 231
2025
Q1
– Sell
-3,375
Closed -$191K – 469
2024
Q4
$191K Buy
3,375
+40
+1% +$2.23K 0.02% 194
2024
Q3
$173K Buy
3,335
+1,308
+65% +$61.4K 0.02% 202
2024
Q2
$84.2K Buy
+2,027
New +$90.7K 0.01% 268
2024
Q1
– Sell
-49
Closed -$2.51K – 335
2023
Q4
$2.51K Buy
+49
New +$2.57K ﹤0.01% 340
2023
Q1
– Sell
-40
Closed -$2.88K – 360
2022
Q4
$2.88K Buy
+40
New +$3.02K ﹤0.01% 386

Other funds holding BMY

Y.D. More Investments's BMY Position: Q2 2026 in Review

Y.D. More Investments increased its Bristol-Myers Squibb (BMY) stake by 3.7% in Q2 2026, buying an estimated $3.9K and bringing the position to 1,914 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #271.

Y.D. More Investments first reported a position in BMY in Q4 2022 and has held it in 9 quarters since. The position peaked at $191K in Q4 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Y.D. More Investments held 1,914 shares of Bristol-Myers Squibb worth $110K as of Q2 2026.
  • Y.D. More Investments bought 68 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.9K.
  • Bristol-Myers Squibb made up ﹤0.01% of Y.D. More Investments's portfolio in Q2 2026, its #271 holding.
  • Y.D. More Investments first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 9 quarters since.
  • Y.D. More Investments's Bristol-Myers Squibb position peaked at $191K in Q4 2024.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Y.D. More Investments's 13F filing for Q2 2026, filed 5 Aug 2026.